Search
for
Sort by
Research 361–390 of 1000+
- Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus
- Alopecia Areata of the Beard: A Review of the Literature
- Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Gut microbiota in alopecia areata
- Non-hemorrhage-related adverse effects of rivaroxaban
- Design of an artificial skin. IV. Use of island graft to isolate organ regeneration from scar synthesis and other processes leading to skin wound closure
- Skin health of community-living older people: a scoping review
- Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- Chemoprevention of doxorubicin-induced alopecia in mice by dietary administration of l-cystine and vitamin B6
- Alopecia - the search for novel agents continues
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Hair loss
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia
- Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort
- Practical Geriatrics: Maintaining Sexual Health After Menopause
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Taste disorders and alopecia in myasthenia gravis
- Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- FDA Reports of Alopecia as an Adverse Event to Isotretinoin
- Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study